Pocket Pet · Octodon degus · typical adult weight 0.17–0.30 kg
Cisapride is dosed at 0.1–0.5 mg/kg PO q8-12h in degus, per Fehr M, Sassenburg L, Zwart P. Krankheiten der Heimtiere, 8th ed., Schluetersche Verlagsgesellschaft, Hannover, Germany; 2015. — Mined from Carpenter's Exotic Animal Formulary, 6th Ed, p.799 (2026-08-01, PENDING REVIEW). Cisapride is used in degus for Gastrointestinal hypomotility. Routes documented in degus: PO. A typical adult degu weighs 0.17–0.30 kg. ExoticRx lists 1 cited dose rule for Cisapride in degus, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Propulsid
| Route | Dose | Frequency | Indication | Evidence | Source |
|---|---|---|---|---|---|
| PO | 0.1–0.5 mg/kg | q8-12h | Gastrointestinal hypomotility | Weak | Fehr M, Sassenburg L, Zwart P. Krankheiten der Heimtiere, 8th ed., Schluetersche Verlagsgesellschaft, Hannover, Germany; 2015. — Mined from Carpenter's Exotic Animal Formulary, 6th Ed, p.799 (2026-08-01, PENDING REVIEW) |
Need the exact dose for your patient?
These ranges are per kg. Enter your degu's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Serotonin 5-HT4 receptor agonist. Enhances acetylcholine release in the myenteric plexus, promoting GI motility throughout the tract.
Withdrawn from human market (cardiac arrhythmias); available as compounded product for veterinary use. Contraindicated with GI obstruction. May interact with azole antifungals.
Species-specific contraindications and adverse-reaction reports for degus may differ from canine / feline reference data — consult the primary citations listed with each rule.
Cisapride dose range in degus, with cited source references: PO 0.1–0.5 mg/kg q8-12h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Cisapride in degus: PO.
Cisapride is indicated in degus for: Gastrointestinal hypomotility.
These are general warnings for Cisapride across species; consult the degu dosing table above for species-specific guidance. Withdrawn from human market (cardiac arrhythmias); available as compounded product for veterinary use. Contraindicated with GI obstruction. May interact with azole antifungals.
Why a species-specific page? Cisapride pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in degus — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.